loading

Loading...

Archive by Tag: KOL

TBJ_Reviewing Dr Payments

Triangle Business Journal Selects Meade for Guest Column

In the wake of the Sunshine Act’s Open Payments database launch, press detailing payments made to doctors by the pharma and medical device industries is fueling speculation about the negative impact this development could have on industry. Given the Raleigh-Durham[...]

FDANews-thumb

Meade Featured as Sunshine Disclosure Expert

As disclosures of life science industry payments to healthcare professionals continue with rollouts such as the Centers for Medicare and Medicaid Services’ Open Payments Database in late September, Thought Leader Select’s Paul Meade has been a sought-after expert on the[...]

diabetes

Thought Leader Select Customizes KOL Identification Methodologies in Support of Global Diabetes Initiatives

By Brian Castle Throughout most of 2014, Thought Leader Select has been privileged to work with a top-five global biopharmaceutical giant in support of its diabetes portfolio in across the globe.  For this particular engagement, across several countries with cultural[...]

Biopharma Re-engages Thought Leader Select for KOL Work in Bacterial Infections

December 10, 2013 (CHAPEL HILL, NC) Thought Leader Select, a consulting firm to the life sciences industries, recently earned a new client engagement to support key opinion leader (KOL) strategies for new treatments in the area of bacterial infections. The client[...]

US Biopharma Chooses Thought Leader Select for KOL Initiatives in Lupus

December 4, 2013 (CHAPEL HILL, NC) Thought Leader Select, a consulting firm to the life sciences industries, is working with a U.S. biopharmaceutical company on key opinion leader (KOL) initiatives in systemic lupus. The client company, a leader in developing new[...]

Global Pharma Giant Tabs Thought Leader Select to Optimize KOL Engagements in Diabetes

November 26, 2013 (CHAPEL HILL, NC) Thought Leader Select, a consulting firm to the life sciences industries, recently earned new work in support of global key opinion leader (KOL) initiatives in diabetes for a top five global biopharmaceutical company. The client[...]

Biopharma Giant Tabs Thought Leader Select for Initiatives in Companion Diagnostics for Oncology Products

July 9, 2013 (CHAPEL HILL, NC) A global biopharmaceutical leader has chosen Thought Leader Select to perform critical research and advisory work in support of key opinion leader initiatives advancing companion diagnostics for oncology medications. Thought Leader Select, headquartered in Chapel[...]

Global Pharmas Choose Thought Leader Select as Vendor of Choice for KOL Initiatives

(CHAPEL HILL, NC) Canadian subsidiaries of a pair of top-15 global biopharmaceutical companies have appointed Thought Leader Select as their preferred research and engagement advisor for key opinion leader initiatives in multiple therapeutic areas. Thought Leader Select, headquartered in Chapel Hill,[...]

US Biopharma Retains Thought Leader Select for GI Initiatives with KOLs, Centers of Excellence

June 13, 2013 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a medical strategy engagement in gastroenterology with a leading U.S. biopharmaceutical company. The company,[...]

Canadian Pharma Chooses Thought Leader Select for COPD Key Opinion Leader Engagement Strategy

December 20, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a medical strategy engagement in pulmonology with a top Canadian biopharmaceutical company. The company,[...]